首页 | 本学科首页   官方微博 | 高级检索  
     

重度左心衰患者弥散功能降低的临床研究报告*
引用本文:谭晓越,孙兴国,胡盛寿,张健,黄洁,陈志高,马莉. 重度左心衰患者弥散功能降低的临床研究报告*[J]. 中国应用生理学杂志, 2015, 31(4): 357-360. DOI: 10.12047/j.cjap.0120.2015.015
作者姓名:谭晓越  孙兴国  胡盛寿  张健  黄洁  陈志高  马莉
作者单位:中国医学科学院 北京协和医学院 国家心血管病中心阜外医院 心血管疾病国家重点实验室, 心血管疾病国家临床医学研究中心, 北京 100037
基金项目:*国家自然科学基金医学科学部面上项目(81470204); 国家高新技术研究发展计划(863计划)课题(2012AA021009); 中国医学科学院国家心血管病中心科研开发启动基金(2012-YJR02)
摘    要:目的: 观察重度左心衰竭患者肺弥散功能(DLCO)变化的临床特点,探讨其潜在的病理生理学机制及其临床意义。方法: 回顾性分析28例重度左心衰患者的临床资料、DLCO、肺通气功能和心肺运动试验指标。结果: 左心衰竭患者的峰值摄氧量严重降低为34±7%pred和无氧阈为48±11%pred,DLCO中度降低为63±12%pred 。28例患者有25例DLCO低于80%pred,而用力肺活量、第一秒用力肺活量、第一秒用力肺活量/用力肺活量和肺总量分别为75±14 、71±17、97±11和79±13%pred,提示通气功能呈边界性至轻度限制性障碍。DLCO的下降幅度显著大于肺通气指标。结论: 具有极严重心肺功能受限的重度心衰患者,DLCO显著降低和仅仅边界性轻度限制性通气受限。DLCO是心肺协同功能指标,在无明显呼吸受限前提下是反映循环功能受限的指标。

关 键 词:心力衰竭  弥散功能  肺功能  心肺运动试验  整合整合生理学  整体整合医学  新理论  
收稿时间:2015-06-05

Preliminary study of clinical significance of decreased DLCO in patients with left ventricular heart failure
TAN Xiao-yue,SUN Xing-guo,HU Sheng-shou,ZHANG Jian,HUANG Jie,CHEN Zhi-gao,MA Li. Preliminary study of clinical significance of decreased DLCO in patients with left ventricular heart failure[J]. Chinese journal of applied physiology, 2015, 31(4): 357-360. DOI: 10.12047/j.cjap.0120.2015.015
Authors:TAN Xiao-yue  SUN Xing-guo  HU Sheng-shou  ZHANG Jian  HUANG Jie  CHEN Zhi-gao  MA Li
Affiliation:State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Research Center of Clinic Medicine for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
Abstract:Objective: This study aimed to investigate the feature of DLCO (Diffusion Lung Capacity for Carbon Monoxide) in CHF (left ventricular heart failure) patients, underlying pathophysiological mechanism and clinical significance. Methods: We retrospectively studied the DLCO, pulmonary ventilation function, cardiopulmonary exercise testing and related clinical information in severer HF patients. Results: Peak VO2 severely decreased to 34±7 percentage of predicted(%pred) and anaerobic threshold to 48±11%pred in all patients. DLCO moderately decreased to 63±12%pred and there were 25 patients lower than 80%pred. FVC, FEV1 , FEV1/FVC and TLC were 75±14%pred, 71±17%pred , 97±11%pred, and 79±13%pred, which indicated borderline or mild restrictive ventilatory dysfunction. The decrease of DLCO was more severe than those of TLC, FEV1 and FVC. Conclusion: For patients with severe CHF, cardiopulmonary exercise function is extremely limited, DLCO generally moderately declines and ventilation function is merely mildly limited. DLCO is the parameter for cardiopulmonary coupling, reflecting limitation of the cardiovascular dysfunction while without ventilatory limit.
Keywords:chronic heart failure  diffusion lung capacity for carbon monoxide  pulmonary function test  cardiopulmonary exercise testing  integrated holistic physiology  integrated holistic medicine  new theory  
点击此处可从《中国应用生理学杂志》浏览原始摘要信息
点击此处可从《中国应用生理学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号